Imaging Platform
Precise imaging in oncological research is a key method to measure efficacy of therapeutic procedures. In routine clinical practice, time on high-end imaging devices is scarce. Therefore, the NCT/UCC Imaging Platform has the aim to perform high quality anatomical and functional imaging within preclinical research, clinical trials or prospective registries. Therefore the Core Unit Imaging supports projects on preclinical questions, their translation into clinical context, technical development of imaging acquisition and imaging in clinical trials.
Service (selection)
PET/MRI
- Primary staging of rare tumors
- Staging of recurrent disease following primary treatment
- Longitudinal studies during treatment serving as response monitoring
- Clinical characterization of new PET-Tracers
CT
- preclinical research requiring repeated CT imaging or CT guided interventions
Contact
Katja Riemann
Email: katja.riemann(at)nct-dresden.de
Phone: + 49 (0) 351 458-17846
Antje Senftleben
Email: antje.senftleben(at)nct-dresden.de
Phone: + 49 (0) 351 458-11478
Email: antje.senftleben(at)nct-dresden.de
Phone: + 49 (0) 351 458-11478
>>> Project application form
Dr. Robert Winzer
Email: robert.winzer(at)nct-dresden.de
Phone: + 49 (0) 351 458-18408